Quia Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	May '25 May 13, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	14	16	3	31	39	87	Upgrade
Market Cap Growth	473.25%	473.25%	-91.14%	-20.03%	-55.65%	37.63%	Upgrade
Enterprise Value	15	16	11	39	52	82	Upgrade
Last Close Price	0.01	0.01	0.07	13.00	54.00	157.00	Upgrade
PS Ratio	30.74	34.01	0.62	5.53	4.41	23.23	Upgrade
PB Ratio	0.86	0.96	0.18	12.77	1674.54	1240.71	Upgrade
EV/Sales Ratio	33.15	35.64	2.52	6.98	5.93	21.93	Upgrade
Debt / Equity Ratio	0.07	0.07	1.35	6.44	773.87	82.14	Upgrade
Asset Turnover	0.01	0.01	0.13	0.24	0.39	0.21	Upgrade
Quick Ratio	0.07	0.07	0.03	0.60	0.93	0.48	Upgrade
Current Ratio	0.16	0.16	0.07	0.65	0.94	0.49	Upgrade
Return on Equity (ROE)	-183.07%	-183.07%	-187.09%	-1650.02%	-43010.75%	-	Upgrade
Return on Assets (ROA)	-26.40%	-26.40%	-29.65%	-41.82%	-49.57%	-87.18%	Upgrade
Return on Capital (ROIC)	-32.03%	-32.03%	-36.04%	-55.21%	-92.89%	-214.00%	Upgrade
Earnings Yield	-204.60%	-184.91%	-605.43%	-65.22%	-51.93%	-31.91%	Upgrade
FCF Yield	-	-65.01%	-376.16%	-59.02%	-52.42%	-33.25%	Upgrade
Buyback Yield / Dilution	-1173.14%	-1173.14%	-4105.13%	-182.75%	-51.66%	-33.80%	Upgrade
Total Shareholder Return	-1173.14%	-1173.14%	-4105.13%	-182.75%	-51.66%	-33.80%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.